ramelteon + escitalopram

Ramelteon + escitalopram is a combination of two pharmaceutical drugs used for their respective indications. Ramelteon is a melatonin receptor agonist indicated for the treatment of insomnia, particularly difficulty with sleep onset. It acts by selectively binding to melatonin MT1 and MT2 receptors in the suprachiasmatic nucleus (SCN) of the brain, thereby regulating circadian rhythms and promoting sleep[3][6][8]. Escitalopram is a selective serotonin reuptake inhibitor (SSRI) indicated for major depressive disorder and generalized anxiety disorder. It works by inhibiting the serotonin transporter (SERT), increasing synaptic serotonin levels in the central nervous system[5]. The combination may be prescribed when both insomnia and depression or anxiety are present; however, co-administration can increase side effects such as dizziness, drowsiness, confusion, and impaired concentration[1].

Other names

ramelteonescitalopram